Cti Biopharma Corp

UBS Group AG

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

Shares

402,893

Value ($000)

1,692

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	1,692	0.0%	402,893	3/31/2023
2022 Q4	2/8/2023	5,567	0.0%	926,309	12/31/2022
2022 Q3	11/10/2022	840	0.0%	144,256	9/30/2022
2022 Q2	8/10/2022	1,656	0.0%	277,500	6/30/2022
2022 Q1	5/16/2022	78	0.0%	16,734	3/31/2022
2021 Q4	2/14/2022	10	0.0%	4,017	12/31/2021
2021 Q3	11/15/2021	13	0.0%	4,278	9/30/2021
2021 Q2	8/13/2021	17	0.0%	6,747	6/30/2021
2021 Q1	5/12/2021	29	0.0%	9,971	3/31/2021
2020 Q4	2/11/2021	14	0.0%	4,278	12/31/2020
2020 Q3	11/12/2020	10	0.0%	4,862	9/30/2020
2020 Q2	7/31/2020	30	0.0%	25,862	6/30/2020
2020 Q1	5/1/2020	16	0.0%	17,667	3/31/2020
2019 Q4	2/14/2020	15	0.0%	9,404	12/31/2019